Trial · NCT03399175
Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
NCT03399175, Not applicable, Recruiting, University of Sao Paulo
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease. Trials, record NCT03399175. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03399175
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
- NCT number
- NCT03399175
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- University of Sao Paulo
- Conditions
- Vogt Koyanagi Harada Disease
- Interventions
- Early high-dose corticosteroid and immunosuppressive therapy
- First posted
- 2018-01-16
- Last updated
- 2026-05-07
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | scotopic electroretinogram results | 6 month; 12 month | scotopic results variation between 12 months and 6 months |
| Secondary | presence of optic disc hyperfluorescence detected on fluorescein angiography | between 6 and 12 months from disease onset. | presence of optic disc hyperfluorescence and variation in intensity in consecutive examinations |
| Secondary | presence of perivascular leakage on fluorescein angiography | between 6 and 12 months from disease onset. | presence of perivascular leakage and variation in extension and intensity in consecutive examinations |
| Secondary | presence of dark dots on indocyanine green angiography | between 6 and 12 months from disease onset. | dark dots score and its fluctuation |
| Secondary | subfoveal choroidal thickness on enhanced depth imaging optical coherence tomography | between 6 and 12 months from disease onset. | subfoveal choroidal thickness and its variation |
| Secondary | presence of cells in anterior chamber graduated according to SUN criteria | between 6 and 12 months from disease onset. | presence of cells in anterior chamber and its variation |
| Secondary | presence of choroidal neovascular membrane on OCT and/or FA | between 6 and 12 months from disease onset. | choroidal neovascular membrane |
| Secondary | presence of macular edema on OCT and/or FA | between 6 and 12 months from disease onset. | macular edema detected clinically, angiographically and/or by optical coherence tomography |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers11
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03399175
GET https://conductscience.org/api/trials/v1/NCT03399175/registered